Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancy

Clinical Immunology

Volumn 112, Issue 3, 2004, Pages 221-224

  Al Ramadi, Basel K ^a   Ellis, Michael ^a   Pasqualini, Fabio ^b   Mantovani, Alberto ^c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Haematological patients; Inflammatory mediators; Innate immunity; Invasive aspergillosis; Microbial infections; Soluble immune factors

Indexed keywords

PENTRAXIN 3; PLASMA PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; ASPERGILLOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFECTION COMPLICATION; INFLAMMATION; MALE; MUCOSA INFLAMMATION; MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR INTRINSIC ACTIVITY;

C-REACTIVE PROTEIN; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFECTION; MALE; SERUM AMYLOID P-COMPONENT; SOLUBILITY;

EID: 4043184173     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.03.012     Document Type: Article

References (8)

1. Mantovani A., Garlanda C., Bottazzi B. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine. 21:2003;S2/43-S2/47
2. Muller B., Peri G., Doni A., Torri V., Landmann R., Bottazzi B., Mantovani A. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit. Care Med. 29:2001;1404-1407
3. Hauggaard A., Ellis M., Ekelund L. Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. Acta Radiol. 43:2002;292-298
4. Peri G., Introna M., Corradi D., Iaccuitti G., Signorini S., Avanzini F., Maggioni A.P., Moccetti T., Metra M., Cas L.D., Ghezzi P., Sipe J.D., Re G., Olivetti G., Mantovani A., Latini R. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation. 102:2000;636-641
5. Ellis M., Zwaan F., Hedstrom U., Poynton C., Kristensen J., Jumaa P., Wassell J., al-Ramadi B. Recombinant interleukin 11 and bacterial infection in patients with haematological malignancy undergoing chemotherapy: a double-blind placebo-controlled randomized trial. Lancet. 361:2003;275-280
6. Rovere P., Peri G., Fazzini F., Bottazzi B., Doni A., Bondanza A., Zimmermann V.S., Garlanda C., Fascio U., Sabbadini M.G., Rugarli C., Mantovani A., Manfredi A.A. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood. 96:2000;4300-4306
7. Keefe D.M., Brealey J., Goland G.J., Cummins A.G. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine. Gut. 47:2000;632-637
8. Garlanda C., Hirsch E., Bozza S., Salustri A., De Acetis M., Nota R., Maccagno A., Riva F., Bottazzi B., Peri G., Doni A., Vago L., Botto M., De Santis R., Carminati P., Siracusa G., Altruda F., Vecchi A., Romani L., Mantovani A. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature. 420:2002;182-186